AFCM
UTHR icon

Applied Finance Capital Management’s United Therapeutics UTHR Stock Holding History

Applied Finance Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Sell
521
-45
-8% -$25.3K 0.02% 188
2026
Q1 		$336K Sell
566
-3
-0.5% -$1.49K 0.03% 177
2025
Q4 		$277K Sell
569
-350
-38% -$163K 0.02% 204
2025
Q3 		$385K Sell
919
-174
-16% -$58.5K 0.03% 205
2025
Q2 		$314K Sell
1,093
-39
-3% -$11.7K 0.02% 245
2025
Q1 		$349K Buy
1,132
+40
+4% +$13.7K 0.03% 229
2024
Q4 		$385K Hold
1,092
– – 0.02% 226
2024
Q3 		$391K Hold
1,092
– – 0.02% 226
2024
Q2 		$348K Buy
+1,092
New +$289K 0.02% 236

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Applied Finance Capital Management's UTHR Position: Q2 2026 in Review

Applied Finance Capital Management reduced its United Therapeutics (UTHR) stake by 8% in Q2 2026, selling an estimated $25.3K and leaving 521 shares worth $283K. The position accounts for 0.02% of the portfolio, ranked #188.

Applied Finance Capital Management first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $391K in Q3 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Applied Finance Capital Management held 521 shares of United Therapeutics worth $283K as of Q2 2026.
  • Applied Finance Capital Management sold 45 United Therapeutics shares in Q2 2026, an estimated $25.3K.
  • United Therapeutics made up 0.02% of Applied Finance Capital Management's portfolio in Q2 2026, its #188 holding.
  • Applied Finance Capital Management first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Applied Finance Capital Management's United Therapeutics position peaked at $391K in Q3 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.